Cargando…

Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients

BACKGROUND: Non-gastrointestinal stromal tumor soft-tissue sarcomas (non-GIST STSs) constitute a heterogeneous group of tumors with poor prognosis. Fibroblast growth factor 2 (FGF2) and fibroblast growth factor receptor-1 (FGFR-1), in close interplay with platelet-derived growth factor-B (PDGF-B) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kilvaer, Thomas K, Valkov, Andrej, Sorbye , Sveinung W, Smeland, Eivind, Bremnes, Roy M, Busund, Lill-Tove, Donnem, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141498/ https://www.ncbi.nlm.nih.gov/pubmed/21733164 http://dx.doi.org/10.1186/1479-5876-9-104

Ejemplares similares

Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival
por: Kilvaer, Thomas Karsten, et al.
Publicado: (2010)

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
por: Kilvaer, Thomas K, et al.
Publicado: (2014)

Profiling of VEGFs and VEGFRs as Prognostic Factors in Soft Tissue Sarcoma: VEGFR-3 Is an Independent Predictor of Poor Prognosis
por: Kilvaer, Thomas K., et al.
Publicado: (2010)

The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011)

The Prognostic Impact of TGF-β1, Fascin, NF-κB and PKC-ζ Expression in Soft Tissue Sarcomas
por: Valkov, Andrej, et al.
Publicado: (2011)

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
por: Smeland, Eivind, et al.
Publicado: (2012)

Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2011)

Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2012)

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2012)

Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
por: Sorbye, Sveinung W, et al.
Publicado: (2013)

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
por: Kilvaer, Thomas Karsten, et al.
Publicado: (2018)

High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome
por: Stenvold, Helge, et al.
Publicado: (2014)

Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer - A Structured Review with Meta-Analysis
por: Kilvaer, Thomas K., et al.
Publicado: (2015)

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers
por: Kilvaer, Thomas K., et al.
Publicado: (2015)

Digitally quantified CD8(+) cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
por: Kilvaer, Thomas K, et al.
Publicado: (2020)

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
por: Al-Saad, Samer, et al.
Publicado: (2017)

Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
por: Donnem, Tom, et al.
Publicado: (2011)

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
por: Paulsen, Erna-Elise, et al.
Publicado: (2017)

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
por: Rakaee, Mehrdad, et al.
Publicado: (2016)

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
por: Stenvold, Helge, et al.
Publicado: (2014)

Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization) study
por: Andersen, Sigve, et al.
Publicado: (2016)

The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
por: Ness, Nora, et al.
Publicado: (2017)

High expression of microRNA-126 relates to favorable prognosis for colon cancer patients
por: Selven, Hallgeir, et al.
Publicado: (2021)

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
por: Paulsen, Erna-Elise, et al.
Publicado: (2023)

Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6
por: Melbø-Jørgensen, Christian, et al.
Publicado: (2014)

The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
por: Kilvaer, Thomas K, et al.
Publicado: (2016)

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry()
por: Rakaee, Mehrdad, et al.
Publicado: (2019)

A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
por: Skjefstad, Kaja, et al.
Publicado: (2018)

Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
por: Andersen, Sigve, et al.
Publicado: (2011)

Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2
por: Andersen, Sigve, et al.
Publicado: (2011)

Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
por: Hald, Sigurd M., et al.
Publicado: (2015)

Erratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
por: Hald, Sigurd M., et al.
Publicado: (2016)

High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?
por: Nordby, Yngve, et al.
Publicado: (2017)

CD45RO(+) Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer()
por: Paulsen, Erna-Elise, et al.
Publicado: (2015)

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
por: Nordby, Yngve, et al.
Publicado: (2017)

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC
por: Kilvaer, Thomas Karsten, et al.
Publicado: (2019)

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time
por: Andersen, Sigve, et al.
Publicado: (2014)

High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure
por: Grindstad, Thea, et al.
Publicado: (2015)

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
por: Eilertsen, Marte, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3ptfa923erqoh3hm76gun6lmcl